ACI
ELV icon

Advance Capital I’s Elevance Health ELV Stock Holding History

Advance Capital I’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$238K Buy
+1,900
New +$245K 0.48% 81
2016
Q2 		– Sell
-3,100
Closed -$431K – 165
2016
Q1 		$431K Buy
3,100
+200
+7% +$26.7K 0.45% 90
2015
Q4 		$404K Buy
+2,900
New +$399K 0.38% 80

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Advance Capital I's ELV Position: Q3 2016 in Review

Advance Capital I opened a new position in Elevance Health (ELV) in Q3 2016: 1,900 shares worth $238K. The stake represents 0.48% of the portfolio and ranks #81 among its holdings. This is a return to the name: Advance Capital I previously reported a position in ELV as recently as Q1 2016.

Advance Capital I first reported a position in ELV in Q4 2015 and has held it in 3 quarters since. The position peaked at $431K in Q1 2016. 735 funds tracked by Wall St. Rank hold ELV as of Q3 2016.

  • Advance Capital I held 1,900 shares of Elevance Health worth $238K as of Q3 2016.
  • Elevance Health was a new Advance Capital I position in Q3 2016.
  • Elevance Health made up 0.48% of Advance Capital I's portfolio in Q3 2016, its #81 holding.
  • Advance Capital I first reported a position in Elevance Health in Q4 2015 and has held it in 3 quarters since.
  • Advance Capital I's Elevance Health position peaked at $431K in Q1 2016.
  • 735 funds tracked by Wall St. Rank held Elevance Health as of Q3 2016.

Based on Advance Capital I's 13F filing for Q3 2016, filed 1 Nov 2016.